{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:28:12Z","timestamp":1794079692748,"version":"4.8.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00415-024-12538-3","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T15:01:42Z","timestamp":1719932502000},"page":"5778-5803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["French National Protocol for diagnosis and care of facioscapulohumeral muscular dystrophy (FSHD)"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7211-4694","authenticated-orcid":false,"given":"Shahram","family":"Attarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Beloribi-Djefaflia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaelle","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Cances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Gavazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andoni","family":"Echaniz-Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Espil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresinha","family":"Evangelista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9onard","family":"Feasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Audic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Zagorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Milhe De Bovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Stojkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilhem","family":"Sole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Salort-Campana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Sacconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,2]]},"reference":[{"key":"12538_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13023-018-0960-x","volume":"13","author":"C Guien","year":"2018","unstructured":"Guien C, Blandin G, Lahaut P et al (2018) The French National Registry of patients with facioscapulohumeral muscular dystrophy. Orphanet J Rare Dis 13:218. https:\/\/doi.org\/10.1186\/s13023-018-0960-x","journal-title":"Orphanet J Rare Dis"},{"issue":"S13","key":"12538_CR2","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1002\/mus.880181315","volume":"18","author":"GW Padberg","year":"1995","unstructured":"Padberg GW, Frants RR, Brouwer OF et al (1995) Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve Suppl 18(S13):S81\u2013S84","journal-title":"Muscle Nerve Suppl"},{"key":"12538_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1399-0004.2009.01158.x","volume":"75","author":"M Mostacciuolo","year":"2009","unstructured":"Mostacciuolo M, Pastorello E, Vazza G et al (2009) Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Clin Genet 75:550\u2013555. https:\/\/doi.org\/10.1111\/j.1399-0004.2009.01158.x","journal-title":"Clin Genet"},{"key":"12538_CR4","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","volume":"83","author":"JCW Deenen","year":"2014","unstructured":"Deenen JCW, Arnts H, van der Maarel SM et al (2014) Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 83:1056\u20131059. https:\/\/doi.org\/10.1212\/WNL.0000000000000797","journal-title":"Neurology"},{"key":"12538_CR5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1212\/WNL.0b013e3182a84140","volume":"81","author":"KL Lutz","year":"2013","unstructured":"Lutz KL, Holte L, Kliethermes SA et al (2013) Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy. Neurology 81:1374\u20131377. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a84140","journal-title":"Neurology"},{"key":"12538_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/practneurol-2015-001353","volume":"16","author":"K Mul","year":"2016","unstructured":"Mul K, Lassche S, Voermans NC et al (2016) What\u2019s in a name? The clinical features of facioscapulohumeral muscular dystrophy. Pract Neurol 16:201\u2013207","journal-title":"Pract Neurol"},{"key":"12538_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/humu.21091","volume":"30","author":"JC de Greef","year":"2009","unstructured":"de Greef JC, Lemmers RJLF, van Engelen BGM et al (2009) Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum Mutat 30:1449\u20131459. https:\/\/doi.org\/10.1002\/humu.21091","journal-title":"Hum Mutat"},{"key":"12538_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mus.24218","volume":"50","author":"MA Scully","year":"2014","unstructured":"Scully MA, Eichinger KJ, Donlin-Smith CM et al (2014) Restrictive lung involvement in facioscapulohumeral muscular dystrophy. Muscle Nerve 50:739\u2013743. https:\/\/doi.org\/10.1002\/mus.24218","journal-title":"Muscle Nerve"},{"key":"12538_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/cge.13446","volume":"94","author":"K Mul","year":"2018","unstructured":"Mul K, Voermans NC, Lemmers RJLF et al (2018) Phenotype\u2013genotype relations in facioscapulohumeral muscular dystrophy type 1. Clin Genet 94:521\u2013527. https:\/\/doi.org\/10.1111\/cge.13446","journal-title":"Clin Genet"},{"key":"12538_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1086\/302730","volume":"66","author":"SM van der Maarel","year":"2000","unstructured":"van der Maarel SM, Deidda G, Lemmers RJ et al (2000) De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet 66:26\u201335. https:\/\/doi.org\/10.1086\/302730","journal-title":"Am J Hum Genet"},{"key":"12538_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00439-005-0100-2","volume":"119","author":"MMO Tonini","year":"2006","unstructured":"Tonini MMO, Lemmers RJLF, Pavanello RCM et al (2006) Equal proportions of affected cells in muscle and blood of a mosaic carrier of facioscapulohumeral muscular dystrophy. Hum Genet 119:23\u201328. https:\/\/doi.org\/10.1007\/s00439-005-0100-2","journal-title":"Hum Genet"},{"key":"12538_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1136\/jmg.33.5.366","volume":"33","author":"R Tupler","year":"1996","unstructured":"Tupler R, Berardinelli A, Barbierato L et al (1996) Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J Med Genet 33:366\u2013370. https:\/\/doi.org\/10.1136\/jmg.33.5.366","journal-title":"J Med Genet"},{"key":"12538_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jmedgenet-2018-105949","volume":"56","author":"K Nguyen","year":"2019","unstructured":"Nguyen K, Broucqsault N, Chaix C et al (2019) Deciphering the complexity of the 4q and 10q subtelomeres by molecular combing in healthy individuals and patients with facioscapulohumeral dystrophy. J Med Genet 56:590\u2013601. https:\/\/doi.org\/10.1136\/jmedgenet-2018-105949","journal-title":"J Med Genet"},{"key":"12538_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ng1262","volume":"35","author":"PGM van Overveld","year":"2003","unstructured":"van Overveld PGM, Lemmers RJFL, Sandkuijl LA et al (2003) Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat Genet 35:315\u2013317. https:\/\/doi.org\/10.1038\/ng1262","journal-title":"Nat Genet"},{"key":"12538_CR15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1086\/521986","volume":"81","author":"RJLF Lemmers","year":"2007","unstructured":"Lemmers RJLF, Wohlgemuth M, van der Gaag KJ et al (2007) Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am J Hum Genet 81:884\u2013894. https:\/\/doi.org\/10.1086\/521986","journal-title":"Am J Hum Genet"},{"key":"12538_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2454","author":"RJLF Lemmers","year":"2012","unstructured":"Lemmers RJLF, Tawil R, Petek LM et al (2012) Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet. https:\/\/doi.org\/10.1038\/ng.2454","journal-title":"Nat Genet"},{"key":"12538_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ng.3765","volume":"49","author":"CT Gordon","year":"2017","unstructured":"Gordon CT, Xue S, Yigit G et al (2017) De novo mutations in SMCHD1 cause Bosma arhinia microphthalmia syndrome and abrogate nasal development. Nat Genet 49:249\u2013255. https:\/\/doi.org\/10.1038\/ng.3765","journal-title":"Nat Genet"},{"key":"12538_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/jmedgenet-2017-105153","volume":"55","author":"J Balog","year":"2018","unstructured":"Balog J, Goossens R, Lemmers RJLF et al (2018) Monosomy 18p is a risk factor for facioscapulohumeral dystrophy. J Med Genet 55:469\u2013478. https:\/\/doi.org\/10.1136\/jmedgenet-2017-105153","journal-title":"J Med Genet"},{"key":"12538_CR19","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1038\/mt.2012.68","volume":"20","author":"LM Wallace","year":"2012","unstructured":"Wallace LM, Liu J, Domire JS et al (2012) RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy. Mol Ther 20:1417\u20131423. https:\/\/doi.org\/10.1038\/mt.2012.68","journal-title":"Mol Ther"},{"key":"12538_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.nmd.2016.09.015","volume":"26","author":"LV Gatica","year":"2016","unstructured":"Gatica LV, Rosa AL (2016) A complex interplay of genetic and epigenetic events leads to abnormal expression of the DUX4 gene in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 26:844\u2013852. https:\/\/doi.org\/10.1016\/j.nmd.2016.09.015","journal-title":"Neuromuscul Disord"},{"key":"12538_CR21","doi-asserted-by":"publisher","first-page":"16957","DOI":"10.1038\/s41598-018-35150-8","volume":"8","author":"D Bosnakovski","year":"2018","unstructured":"Bosnakovski D, Gearhart MD, Toso EA et al (2018) Low level DUX4 expression disrupts myogenesis through deregulation of myogenic gene expression. Sci Rep 8:16957. https:\/\/doi.org\/10.1038\/s41598-018-35150-8","journal-title":"Sci Rep"},{"key":"12538_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-007798","volume":"6","author":"A Nikolic","year":"2016","unstructured":"Nikolic A, Ricci G, Sera F et al (2016) Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1\u20133 D4Z4 reduced alleles: experience of the FSHD Italian National Registry. BMJ Open 6:e007798. https:\/\/doi.org\/10.1136\/bmjopen-2015-007798","journal-title":"BMJ Open"},{"key":"12538_CR23","doi-asserted-by":"publisher","first-page":"3408","DOI":"10.1093\/brain\/awt226","volume":"136","author":"G Ricci","year":"2013","unstructured":"Ricci G, Scionti I, Sera F et al (2013) Large scale genotype\u2013phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy. Brain 136:3408\u20133417. https:\/\/doi.org\/10.1093\/brain\/awt226","journal-title":"Brain"},{"key":"12538_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-014-0218-1","volume":"10","author":"E Salort-Campana","year":"2015","unstructured":"Salort-Campana E, Nguyen K, Bernard R et al (2015) Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study. Orphanet J Rare Dis 10:2. https:\/\/doi.org\/10.1186\/s13023-014-0218-1","journal-title":"Orphanet J Rare Dis"},{"key":"12538_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/mus.24621","volume":"52","author":"JM Statland","year":"2015","unstructured":"Statland JM, Shah B, Henderson D et al (2015) Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies. Muscle Nerve 52:521\u2013526. https:\/\/doi.org\/10.1002\/mus.24621","journal-title":"Muscle Nerve"},{"key":"12538_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.4040","volume":"3","author":"L Ruggiero","year":"2020","unstructured":"Ruggiero L, Mele F, Manganelli F et al (2020) Phenotypic variability among patients with D4Z4 reduced allele facioscapulohumeral muscular dystrophy. JAMA Netw Open 3:e204040. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.4040","journal-title":"JAMA Netw Open"},{"key":"12538_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2003.008755","volume":"41","author":"K Goto","year":"2004","unstructured":"Goto K, Nishino I, Hayashi YK (2004) Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy 1A. J Med Genet 41:e12. https:\/\/doi.org\/10.1136\/jmg.2003.008755","journal-title":"J Med Genet"},{"key":"12538_CR28","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1093\/hmg\/dds284","volume":"21","author":"TI Jones","year":"2012","unstructured":"Jones TI, Chen JCJ, Rahimov F et al (2012) Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet 21:4419\u20134430. https:\/\/doi.org\/10.1093\/hmg\/dds284","journal-title":"Hum Mol Genet"},{"key":"12538_CR29","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.2174\/1566524014666141010155054","volume":"14","author":"G Ricci","year":"2014","unstructured":"Ricci G, Zatz M, Tupler R (2014) Facioscapulohumeral muscular dystrophy: more complex than it appears. Curr Mol Med 14:1052\u20131068. https:\/\/doi.org\/10.2174\/1566524014666141010155054","journal-title":"Curr Mol Med"},{"key":"12538_CR30","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.3390\/ijms21072635","volume":"21","author":"A Nikolic","year":"2020","unstructured":"Nikolic A, Jones TI, Govi M et al (2020) Interpretation of the epigenetic signature of facioscapulohumeral muscular dystrophy in light of genotype\u2013phenotype studies. Int J Mol Sci 21:2635. https:\/\/doi.org\/10.3390\/ijms21072635","journal-title":"Int J Mol Sci"},{"key":"12538_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12920-019-0488-5","volume":"12","author":"N Zernov","year":"2019","unstructured":"Zernov N, Skoblov M (2019) Genotype\u2013phenotype correlations in FSHD. BMC Med Genomics 12:43. https:\/\/doi.org\/10.1186\/s12920-019-0488-5","journal-title":"BMC Med Genomics"},{"key":"12538_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10048-019-00575-4","volume":"20","author":"S Zampatti","year":"2019","unstructured":"Zampatti S, Colantoni L, Strafella C et al (2019) Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era. Neurogenetics 20:57\u201364. https:\/\/doi.org\/10.1007\/s10048-019-00575-4","journal-title":"Neurogenetics"},{"key":"12538_CR33","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000372","volume":"5","author":"S Roche","year":"2019","unstructured":"Roche S, Dion C, Broucqsault N et al (2019) Methylation hotspots evidenced by deep sequencing in patients with facioscapulohumeral dystrophy and mosaicism. Neurol Genet 5:e372. https:\/\/doi.org\/10.1212\/NXG.0000000000000372","journal-title":"Neurol Genet"},{"key":"12538_CR34","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ejhg.2014.191","volume":"23","author":"M Larsen","year":"2015","unstructured":"Larsen M, Rost S, El Hajj N et al (2015) Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Hum Genet 23:808\u2013816. https:\/\/doi.org\/10.1038\/ejhg.2014.191","journal-title":"Eur J Hum Genet"},{"key":"12538_CR35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1093\/hmg\/ddx437","volume":"27","author":"JC de Greef","year":"2018","unstructured":"de Greef JC, Krom YD, den Hamer B et al (2018) Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model. Hum Mol Genet 27:716\u2013731. https:\/\/doi.org\/10.1093\/hmg\/ddx437","journal-title":"Hum Mol Genet"},{"key":"12538_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003550","volume":"9","author":"N Caruso","year":"2013","unstructured":"Caruso N, Herberth B, Bartoli M et al (2013) Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet 9:e1003550. https:\/\/doi.org\/10.1371\/journal.pgen.1003550","journal-title":"PLoS Genet"},{"key":"12538_CR37","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/ana.24446","volume":"78","author":"V Mariot","year":"2015","unstructured":"Mariot V, Roche S, Hourd\u00e9 C et al (2015) Correlation between low FAT1 expression and early affected muscle in facioscapulohumeral muscular dystrophy. Ann Neurol 78:387\u2013400. https:\/\/doi.org\/10.1002\/ana.24446","journal-title":"Ann Neurol"},{"key":"12538_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/humu.22760","volume":"36","author":"F Puppo","year":"2015","unstructured":"Puppo F, Dionnet E, Gaillard M-C et al (2015) Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype. Hum Mutat 36:443\u2013453. https:\/\/doi.org\/10.1002\/humu.22760","journal-title":"Hum Mutat"},{"key":"12538_CR39","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.ajhg.2016.03.013","volume":"98","author":"ML van den Boogaard","year":"2016","unstructured":"van den Boogaard ML, Lemmers RJLF, Balog J et al (2016) Mutations in DNMT3B modify epigenetic repression of the D4Z4 repeat and the penetrance of facioscapulohumeral dystrophy. Am J Hum Genet 98:1020\u20131029. https:\/\/doi.org\/10.1016\/j.ajhg.2016.03.013","journal-title":"Am J Hum Genet"},{"key":"12538_CR40","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1038\/s41467-017-01200-4","volume":"8","author":"CRS Banerji","year":"2017","unstructured":"Banerji CRS, Panamarova M, Hebaishi H et al (2017) PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle. Nat Commun 8:2152. https:\/\/doi.org\/10.1038\/s41467-017-01200-4","journal-title":"Nat Commun"},{"key":"12538_CR41","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31023","volume":"7","author":"AE Campbell","year":"2018","unstructured":"Campbell AE, Shadle SC, Jagannathan S et al (2018) NuRD and CAF-1-mediated silencing of the D4Z4 array is modulated by DUX4-induced MBD3L proteins. Elife 7:e31023. https:\/\/doi.org\/10.7554\/eLife.31023","journal-title":"Elife"},{"key":"12538_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/mus.25953","volume":"57","author":"RM Hightower","year":"2018","unstructured":"Hightower RM, Alexander MS (2018) Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies. Muscle Nerve 57:6\u201315. https:\/\/doi.org\/10.1002\/mus.25953","journal-title":"Muscle Nerve"},{"key":"12538_CR43","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/hmg\/ddz239","volume":"28","author":"C Strafella","year":"2019","unstructured":"Strafella C, Caputo V, Galota RM et al (2019) The variability of SMCHD1 gene in FSHD patients: evidence of new mutations. Hum Mol Genet 28:3912\u20133920. https:\/\/doi.org\/10.1093\/hmg\/ddz239","journal-title":"Hum Mol Genet"},{"key":"12538_CR44","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3390\/ijms21062221","volume":"21","author":"E Salort-Campana","year":"2020","unstructured":"Salort-Campana E, Fatehi F, Beloribi-Djefaflia S et al (2020) Type 1 FSHD with 6\u201310 repeated units: factors underlying severity in index cases and disease penetrance in their relatives attention. Int J Mol Sci 21:2221. https:\/\/doi.org\/10.3390\/ijms21062221","journal-title":"Int J Mol Sci"},{"key":"12538_CR45","doi-asserted-by":"publisher","first-page":"e2273","DOI":"10.1212\/WNL.0000000000007456","volume":"92","author":"S Sacconi","year":"2019","unstructured":"Sacconi S, Briand-Suleau A, Gros M et al (2019) FSHD1 and FSHD2 form a disease continuum. Neurology 92:e2273\u2013e2285. https:\/\/doi.org\/10.1212\/WNL.0000000000007456","journal-title":"Neurology"},{"key":"12538_CR46","doi-asserted-by":"publisher","first-page":"e2441","DOI":"10.1212\/WNL.0000000000009617","volume":"94","author":"K Hamanaka","year":"2020","unstructured":"Hamanaka K, \u0160ikrov\u00e1 D, Mitsuhashi S et al (2020) Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophy. Neurology 94:e2441\u2013e2447. https:\/\/doi.org\/10.1212\/WNL.0000000000009617","journal-title":"Neurology"},{"key":"12538_CR47","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajhg.2012.02.019","volume":"90","author":"I Scionti","year":"2012","unstructured":"Scionti I, Greco F, Ricci G et al (2012) Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 90:628\u2013635. https:\/\/doi.org\/10.1016\/j.ajhg.2012.02.019","journal-title":"Am J Hum Genet"},{"key":"12538_CR48","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/ana.410390610","volume":"39","author":"R Tawil","year":"1996","unstructured":"Tawil R, Forrester J, Griggs RC et al (1996) Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. Ann Neurol 39:744\u2013748. https:\/\/doi.org\/10.1002\/ana.410390610","journal-title":"Ann Neurol"},{"key":"12538_CR49","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/1531-8249(199906)45:6<751::aid-ana9>3.0.co;2-m","volume":"45","author":"E Ricci","year":"1999","unstructured":"Ricci E, Galluzzi G, Deidda G et al (1999) Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 45:751\u2013757. https:\/\/doi.org\/10.1002\/1531-8249(199906)45:6%3c751::aid-ana9%3e3.0.co;2-m","journal-title":"Ann Neurol"},{"key":"12538_CR50","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nmd.2003.07.001","volume":"14","author":"MMO Tonini","year":"2004","unstructured":"Tonini MMO, Passos-Bueno MR, Cerqueira A et al (2004) Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD). Neuromuscul Disord 14:33\u201338. https:\/\/doi.org\/10.1016\/j.nmd.2003.07.001","journal-title":"Neuromuscul Disord"},{"key":"12538_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nmd.2011.11.001","volume":"22","author":"P Sakellariou","year":"2012","unstructured":"Sakellariou P, Kekou K, Fryssira H et al (2012) Mutation spectrum and phenotypic manifestation in FSHD Greek patients. Neuromuscul Disord 22:339\u2013349. https:\/\/doi.org\/10.1016\/j.nmd.2011.11.001","journal-title":"Neuromuscul Disord"},{"key":"12538_CR52","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.4103\/0366-6999.159336","volume":"128","author":"F Lin","year":"2015","unstructured":"Lin F, Wang Z-Q, Lin M-T et al (2015) New insights into genotype\u2013phenotype correlations in chinese facioscapulohumeral muscular dystrophy: a retrospective analysis of 178 patients. Chin Med J (Engl) 128:1707\u20131713. https:\/\/doi.org\/10.4103\/0366-6999.159336","journal-title":"Chin Med J (Engl)"},{"key":"12538_CR53","doi-asserted-by":"publisher","first-page":"1235589","DOI":"10.3389\/fgene.2023.1235589","volume":"14","author":"C Strafella","year":"2023","unstructured":"Strafella C, Caputo V, Bortolani S et al (2023) Whole exome sequencing highlights rare variants in CTCF, DNMT1, DNMT3A, EZH2 and SUV39H1 as associated with FSHD. Front Genet 14:1235589. https:\/\/doi.org\/10.3389\/fgene.2023.1235589","journal-title":"Front Genet"},{"key":"12538_CR54","doi-asserted-by":"publisher","first-page":"21648","DOI":"10.1038\/s41598-020-78578-7","volume":"10","author":"G Ricci","year":"2020","unstructured":"Ricci G, Mele F, Govi M et al (2020) Large genotype\u2013phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis. Sci Rep 10:21648. https:\/\/doi.org\/10.1038\/s41598-020-78578-7","journal-title":"Sci Rep"},{"key":"12538_CR55","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1002\/mus.880181311","volume":"2","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Tawil R, McDermott M et al (1995) Monozygotic twins with facioscapulohumeral dystrophy (FSHD): implications for genotype\/phenotype correlation. FSH-DY Group. Muscle Nerve Suppl 2:S50-55","journal-title":"Muscle Nerve Suppl"},{"key":"12538_CR56","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/jmg.35.9.778","volume":"35","author":"R Tupler","year":"1998","unstructured":"Tupler R, Barbierato L, Memmi M et al (1998) Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. J Med Genet 35:778\u2013783. https:\/\/doi.org\/10.1136\/jmg.35.9.778","journal-title":"J Med Genet"},{"key":"12538_CR57","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.nmd.2018.02.012","volume":"28","author":"K Mul","year":"2018","unstructured":"Mul K, Horlings CGC, Voermans NC et al (2018) Lifetime endogenous estrogen exposure and disease severity in female patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord 28:508\u2013511. https:\/\/doi.org\/10.1016\/j.nmd.2018.02.012","journal-title":"Neuromuscul Disord"},{"key":"12538_CR58","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0092-8674(02)00826-7","volume":"110","author":"D Gabellini","year":"2002","unstructured":"Gabellini D, Green MR, Tupler R (2002) Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110:339\u2013348. https:\/\/doi.org\/10.1016\/s0092-8674(02)00826-7","journal-title":"Cell"},{"key":"12538_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01577-z","author":"VY Vishnu","year":"2024","unstructured":"Vishnu VY, Lemmers RJLF, Reyaz A et al (2024) The first genetically confirmed cohort of facioscapulohumeral muscular dystrophy from Northern India. Eur J Hum Genet. https:\/\/doi.org\/10.1038\/s41431-024-01577-z","journal-title":"Eur J Hum Genet"},{"key":"12538_CR60","unstructured":"Haute autorit\u00e9 de sant\u00e9 (2012) M\u00e9thode d\u2019\u00e9laboration d\u2019un PNDS. In: M\u00e9thode d\u2019\u00e9laboration d\u2019un PNDS. https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2012-12\/guide_methodologique_pnds.pdf. Accessed 19 Dec 2012"},{"issue":"721\u2013728","key":"12538_CR61","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1016\/j.ncl.2014.04.003","volume":"32","author":"J Statland","year":"2014","unstructured":"Statland J, Tawil R (2014) Facioscapulohumeral muscular dystrophy. Neurol Clin 32(721\u2013728):ix. https:\/\/doi.org\/10.1016\/j.ncl.2014.04.003","journal-title":"Neurol Clin"},{"key":"12538_CR62","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ana.25326","volume":"84","author":"RJM Goselink","year":"2018","unstructured":"Goselink RJM, Schreuder THA, van Alfen N et al (2018) Facioscapulohumeral dystrophy in childhood: a nationwide natural history study. Ann Neurol 84:627\u2013637. https:\/\/doi.org\/10.1002\/ana.25326","journal-title":"Ann Neurol"},{"key":"12538_CR63","doi-asserted-by":"publisher","first-page":"e378","DOI":"10.1212\/WNL.0000000000006819","volume":"92","author":"RJM Goselink","year":"2019","unstructured":"Goselink RJM, Mul K, van Kernebeek CR et al (2019) Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy. Neurology 92:e378\u2013e385. https:\/\/doi.org\/10.1212\/WNL.0000000000006819","journal-title":"Neurology"},{"key":"12538_CR64","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.apmr.2014.03.033","volume":"95","author":"A Bergsma","year":"2014","unstructured":"Bergsma A, Murgia A, Cup EH et al (2014) Upper extremity kinematics and muscle activation patterns in subjects with facioscapulohumeral dystrophy. Arch Phys Med Rehabil 95:1731\u20131741. https:\/\/doi.org\/10.1016\/j.apmr.2014.03.033","journal-title":"Arch Phys Med Rehabil"},{"key":"12538_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/sae.12033","volume":"6","author":"BWT Gooding","year":"2014","unstructured":"Gooding BWT, Geoghegan JM, Wallace WA, Manning PA (2014) Scapular winging. Shoulder Elbow 6:4\u201311. https:\/\/doi.org\/10.1111\/sae.12033","journal-title":"Shoulder Elbow"},{"key":"12538_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2522\/ptj.20070104","volume":"88","author":"S Pandya","year":"2008","unstructured":"Pandya S, King WM, Tawil R (2008) Facioscapulohumeral dystrophy. Phys Ther 88:105\u2013113. https:\/\/doi.org\/10.2522\/ptj.20070104","journal-title":"Phys Ther"},{"key":"12538_CR67","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00415-009-5342-9","volume":"257","author":"K Eger","year":"2010","unstructured":"Eger K, Jordan B, Habermann S, Zierz S (2010) Beevor\u2019s sign in facioscapulohumeral muscular dystrophy: an old sign with new implications. J Neurol 257:436\u2013438. https:\/\/doi.org\/10.1007\/s00415-009-5342-9","journal-title":"J Neurol"},{"key":"12538_CR68","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1007\/s00415-010-5858-z","volume":"258","author":"B Jordan","year":"2011","unstructured":"Jordan B, Eger K, Koesling S, Zierz S (2011) Camptocormia phenotype of FSHD: a clinical and MRI study on six patients. J Neurol 258:866\u2013873. https:\/\/doi.org\/10.1007\/s00415-010-5858-z","journal-title":"J Neurol"},{"key":"12538_CR69","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.nmd.2015.04.011","volume":"25","author":"DB Santos","year":"2015","unstructured":"Santos DB, Boussaid G, Stojkovic T et al (2015) Respiratory muscle dysfunction in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 25:632\u2013639. https:\/\/doi.org\/10.1016\/j.nmd.2015.04.011","journal-title":"Neuromuscul Disord"},{"key":"12538_CR70","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/j.jfo.2015.03.024","volume":"38","author":"TN Brignol","year":"2015","unstructured":"Brignol TN (2015) Literature review of the importance of retinal examination in two genetic neuromuscular diseases (DM1 and FSHD). Potential clinical applications. J Fr Ophthalmol 38:e259-260. https:\/\/doi.org\/10.1016\/j.jfo.2015.03.024","journal-title":"J Fr Ophthalmol"},{"key":"12538_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000107431","volume":"13","author":"CP Trevisan","year":"2008","unstructured":"Trevisan CP, Pastorello E, Ermani M et al (2008) Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Audiol Neurootol 13:1\u20136. https:\/\/doi.org\/10.1159\/000107431","journal-title":"Audiol Neurootol"},{"key":"12538_CR72","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.neurol.2013.02.004","volume":"169","author":"S Sacconi","year":"2013","unstructured":"Sacconi S, Desnuelle C (2013) Facioscapulohumeral muscular dystrophy type 2. Rev Neurol (Paris) 169:564\u2013572. https:\/\/doi.org\/10.1016\/j.neurol.2013.02.004","journal-title":"Rev Neurol (Paris)"},{"key":"12538_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000452763","volume":"77","author":"D Mair","year":"2017","unstructured":"Mair D, Huegens-Penzel M, Kress W et al (2017) Leg muscle involvement in facioscapulohumeral muscular dystrophy: comparison between facioscapulohumeral muscular dystrophy types 1 and 2. Eur Neurol 77:32\u201339. https:\/\/doi.org\/10.1159\/000452763","journal-title":"Eur Neurol"},{"key":"12538_CR74","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/dmcn.14142","volume":"61","author":"D Steel","year":"2019","unstructured":"Steel D, Main M, Manzur A et al (2019) Clinical features of facioscapulohumeral muscular dystrophy 1 in childhood. Dev Med Child Neurol 61:964\u2013971. https:\/\/doi.org\/10.1111\/dmcn.14142","journal-title":"Dev Med Child Neurol"},{"key":"12538_CR75","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1007\/s00415-016-8123-2","volume":"263","author":"G Ricci","year":"2016","unstructured":"Ricci G, Ruggiero L, Vercelli L et al (2016) A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes. J Neurol 263:1204\u20131214. https:\/\/doi.org\/10.1007\/s00415-016-8123-2","journal-title":"J Neurol"},{"key":"12538_CR76","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archneur.60.10.1421","volume":"60","author":"M Krasnianski","year":"2003","unstructured":"Krasnianski M, Eger K, Neudecker S et al (2003) Atypical phenotypes in patients with facioscapulohumeral muscular dystrophy 4q35 deletion. Arch Neurol 60:1421\u20131425. https:\/\/doi.org\/10.1001\/archneur.60.10.1421","journal-title":"Arch Neurol"},{"key":"12538_CR77","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clineuro.2011.10.022","volume":"114","author":"E Pastorello","year":"2012","unstructured":"Pastorello E, Cao M, Trevisan CP (2012) Atypical onset in a series of 122 cases with facioscapulohumeral muscular dystrophy. Clin Neurol Neurosurg 114:230\u2013234. https:\/\/doi.org\/10.1016\/j.clineuro.2011.10.022","journal-title":"Clin Neurol Neurosurg"},{"key":"12538_CR78","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mus.21671","volume":"42","author":"C Lamperti","year":"2010","unstructured":"Lamperti C, Fabbri G, Vercelli L et al (2010) A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: the FSHD clinical score. Muscle Nerve 42:213\u2013217. https:\/\/doi.org\/10.1002\/mus.21671","journal-title":"Muscle Nerve"},{"key":"12538_CR79","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/humu.23304","volume":"38","author":"K Nguyen","year":"2017","unstructured":"Nguyen K, Puppo F, Roche S et al (2017) Molecular combing reveals complex 4q35 rearrangements in facioscapulohumeral dystrophy. Hum Mutat 38:1432\u20131441. https:\/\/doi.org\/10.1002\/humu.23304","journal-title":"Hum Mutat"},{"key":"12538_CR80","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.nmd.2015.08.008","volume":"25","author":"J Vasale","year":"2015","unstructured":"Vasale J, Boyar F, Jocson M et al (2015) Molecular combing compared to Southern blot for measuring D4Z4 contractions in FSHD. Neuromuscul Disord 25:945\u2013951. https:\/\/doi.org\/10.1016\/j.nmd.2015.08.008","journal-title":"Neuromuscul Disord"},{"key":"12538_CR81","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/543282","volume":"2015","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Zhang H, Sun Y et al (2015) Serum enzyme profiles differentiate five types of muscular dystrophy. Dis Markers 2015:543282. https:\/\/doi.org\/10.1155\/2015\/543282","journal-title":"Dis Markers"},{"key":"12538_CR82","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16117","volume":"31","author":"P Soontrapa","year":"2024","unstructured":"Soontrapa P, Shahar S, Eauchai L et al (2024) Disease spectrum of myopathies with elevated aldolase and normal creatine kinase. Eur J Neurol 31:e16117. https:\/\/doi.org\/10.1111\/ene.16117","journal-title":"Eur J Neurol"},{"key":"12538_CR83","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ana.24640","volume":"79","author":"G Tasca","year":"2016","unstructured":"Tasca G, Monforte M, Ottaviani P et al (2016) Magnetic resonance imaging in a large cohort of facioscapulohumeral muscular dystrophy patients: pattern refinement and implications for clinical trials. Ann Neurol 79:854\u2013864. https:\/\/doi.org\/10.1002\/ana.24640","journal-title":"Ann Neurol"},{"key":"12538_CR84","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s00415-021-10786-1","volume":"269","author":"M Monforte","year":"2022","unstructured":"Monforte M, Bortolani S, Torchia E et al (2022) Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning. J Neurol 269:2055\u20132063. https:\/\/doi.org\/10.1007\/s00415-021-10786-1","journal-title":"J Neurol"},{"key":"12538_CR85","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1111\/ene.14446","volume":"27","author":"G Giacomucci","year":"2020","unstructured":"Giacomucci G, Monforte M, Diaz-Manera J et al (2020) Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging. Eur J Neurol 27:2604\u20132615. https:\/\/doi.org\/10.1111\/ene.14446","journal-title":"Eur J Neurol"},{"key":"12538_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070993","volume":"8","author":"TA Willis","year":"2013","unstructured":"Willis TA, Hollingsworth KG, Coombs A et al (2013) Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study. PLoS ONE 8:e70993. https:\/\/doi.org\/10.1371\/journal.pone.0070993","journal-title":"PLoS ONE"},{"key":"12538_CR87","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.neurol.2016.08.002","volume":"172","author":"F Fatehi","year":"2016","unstructured":"Fatehi F, Salort-Campana E, Le Troter A et al (2016) Muscle MRI of facioscapulohumeral dystrophy (FSHD): a growing demand and a promising approach. Rev Neurol (Paris) 172:566\u2013571. https:\/\/doi.org\/10.1016\/j.neurol.2016.08.002","journal-title":"Rev Neurol (Paris)"},{"key":"12538_CR88","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/jcsm.12473","volume":"10","author":"M Monforte","year":"2019","unstructured":"Monforte M, Laschena F, Ottaviani P et al (2019) Tracking muscle wasting and disease activity in facioscapulohumeral muscular dystrophy by qualitative longitudinal imaging. J Cachexia Sarcopenia Muscle 10:1258\u20131265. https:\/\/doi.org\/10.1002\/jcsm.12473","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"12538_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183825","volume":"12","author":"F Fatehi","year":"2017","unstructured":"Fatehi F, Salort-Campana E, Le Troter A et al (2017) Long-term follow-up of MRI changes in thigh muscles of patients with facioscapulohumeral dystrophy: a quantitative study. PLoS ONE 12:e0183825. https:\/\/doi.org\/10.1371\/journal.pone.0183825","journal-title":"PLoS ONE"},{"key":"12538_CR90","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/ana.25804","volume":"88","author":"JR Dahlqvist","year":"2020","unstructured":"Dahlqvist JR, Widholm P, Leinhard OD, Vissing J (2020) MRI in neuromuscular diseases: an emerging diagnostic tool and biomarker for prognosis and efficacy. Ann Neurol 88:669\u2013681. https:\/\/doi.org\/10.1002\/ana.25804","journal-title":"Ann Neurol"},{"key":"12538_CR91","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00415-019-09242-y","volume":"266","author":"JR Dahlqvist","year":"2019","unstructured":"Dahlqvist JR, Andersen G, Khawajazada T et al (2019) Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy. J Neurol 266:1127\u20131135. https:\/\/doi.org\/10.1007\/s00415-019-09242-y","journal-title":"J Neurol"},{"key":"12538_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nmd.2022.11.006","volume":"33","author":"IR Woodcock","year":"2023","unstructured":"Woodcock IR, De Valle K, Varma N et al (2023) Correlation between whole body muscle MRI and functional measures in paediatric patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord 33:15\u201323. https:\/\/doi.org\/10.1016\/j.nmd.2022.11.006","journal-title":"Neuromuscul Disord"},{"key":"12538_CR93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.nmd.2022.10.005","volume":"33","author":"M Monforte","year":"2023","unstructured":"Monforte M, Attarian S, Vissing J et al (2023) 265th ENMC international workshop: muscle imaging in facioscapulohumeral muscular dystrophy (FSHD): relevance for clinical trials. 22\u201324 April 2022, Hoofddorp, The Netherlands. Neuromusc Disord 33:65\u201375. https:\/\/doi.org\/10.1016\/j.nmd.2022.10.005","journal-title":"Neuromusc Disord"},{"key":"12538_CR94","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.nmd.2010.04.007","volume":"20","author":"R Tawil","year":"2010","unstructured":"Tawil R, van der Maarel S, Padberg GW, van Engelen BGM (2010) 171st ENMC international workshop: standards of care and management of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 20:471\u2013475. https:\/\/doi.org\/10.1016\/j.nmd.2010.04.007","journal-title":"Neuromuscul Disord"},{"key":"12538_CR95","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1212\/WNL.0000000000001783","volume":"85","author":"R Tawil","year":"2015","unstructured":"Tawil R, Kissel JT, Heatwole C et al (2015) Evidence-based guideline summary: evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophy: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 85:357\u2013364. https:\/\/doi.org\/10.1212\/WNL.0000000000001783","journal-title":"Neurology"},{"key":"12538_CR96","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.nmd.2016.03.007","volume":"26","author":"R Tawil","year":"2016","unstructured":"Tawil R, Mah JK, Baker S et al (2016) Clinical practice considerations in facioscapulohumeral muscular dystrophy Sydney, Australia, 21 September 2015. Neuromuscul Disord 26:462\u2013471. https:\/\/doi.org\/10.1016\/j.nmd.2016.03.007","journal-title":"Neuromuscul Disord"},{"key":"12538_CR97","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/mus.25251","volume":"55","author":"K Eichinger","year":"2017","unstructured":"Eichinger K, Heatwole C, Heininger S et al (2017) Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy. Muscle Nerve 55:333\u2013337. https:\/\/doi.org\/10.1002\/mus.25251","journal-title":"Muscle Nerve"},{"key":"12538_CR98","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.nmd.2005.03.004","volume":"15","author":"C B\u00e9rard","year":"2005","unstructured":"B\u00e9rard C, Payan C, Hodgkinson I et al (2005) A motor function measure for neuromuscular diseases. Construction and validation study. Neuromuscul Disord 15:463\u2013470. https:\/\/doi.org\/10.1016\/j.nmd.2005.03.004","journal-title":"Neuromuscul Disord"},{"key":"12538_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26088","author":"K Eichinger","year":"2018","unstructured":"Eichinger K, Heatwole C, Iyadurai S et al (2018) Facioscapulohumeral muscular dystrophy functional composite outcome measure. Muscle Nerve. https:\/\/doi.org\/10.1002\/mus.26088","journal-title":"Muscle Nerve"},{"key":"12538_CR100","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.nmd.2013.01.008","volume":"23","author":"JM Statland","year":"2013","unstructured":"Statland JM, McDermott MP, Heatwole C et al (2013) Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 23:306\u2013312. https:\/\/doi.org\/10.1016\/j.nmd.2013.01.008","journal-title":"Neuromuscul Disord"},{"key":"12538_CR101","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3233\/THC-130764","volume":"21","author":"G Kurillo","year":"2013","unstructured":"Kurillo G, Chen A, Bajcsy R, Han JJ (2013) Evaluation of upper extremity reachable workspace using kinect camera. Technol Health Care 21:641\u2013656. https:\/\/doi.org\/10.3233\/THC-130764","journal-title":"Technol Health Care"},{"key":"12538_CR102","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/mus.24287","volume":"51","author":"JJ Han","year":"2015","unstructured":"Han JJ, Kurillo G, Abresch RT et al (2015) Reachable workspace in facioscapulohumeral muscular dystrophy (FSHD) by kinect. Muscle Nerve 51:168\u2013175. https:\/\/doi.org\/10.1002\/mus.24287","journal-title":"Muscle Nerve"},{"key":"12538_CR103","doi-asserted-by":"publisher","DOI":"10.46743\/1540-580X\/2021.1971","author":"J Rousch","year":"2021","unstructured":"Rousch J, Heick J, Hawk T et al (2021) Agreement in walking speed measured using four different outcome measures: 6-meter walk test, 10-meter walk test, 2-minute walk test, and 6-minute walk test. Internet J Allied Health Sci Pract. https:\/\/doi.org\/10.46743\/1540-580X\/2021.1971","journal-title":"Internet J Allied Health Sci Pract"},{"key":"12538_CR104","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/mus.27951","volume":"68","author":"A Varma","year":"2023","unstructured":"Varma A, Weinstein J, Seabury J et al (2023) The facioscapulohumeral muscular dystrophy-health index: development and evaluation of a disease-specific outcome measure. Muscle Nerve 68:422\u2013431. https:\/\/doi.org\/10.1002\/mus.27951","journal-title":"Muscle Nerve"},{"key":"12538_CR105","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s11136-015-1013-8","volume":"24","author":"A Dany","year":"2015","unstructured":"Dany A, Barbe C, Rapin A et al (2015) Construction of a quality of life questionnaire for slowly progressive neuromuscular disease. Qual Life Res 24:2615\u20132623. https:\/\/doi.org\/10.1007\/s11136-015-1013-8","journal-title":"Qual Life Res"},{"key":"12538_CR106","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A et al (2010) The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. J Clin Epidemiol 63:1179\u20131194. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.011","journal-title":"J Clin Epidemiol"},{"key":"12538_CR107","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","volume":"305","author":"JE Brazier","year":"1992","unstructured":"Brazier JE, Harper R, Jones NM et al (1992) Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 305:160\u2013164. https:\/\/doi.org\/10.1136\/bmj.305.6846.160","journal-title":"BMJ"},{"key":"12538_CR108","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.nmd.2023.10.018","volume":"35","author":"J Arjomand","year":"2023","unstructured":"Arjomand J, Gabellini D, Voermans N (2023) FSHD international research congress program committee (2024) meeting report: the 2023 FSHD international research congress. Neuromuscul Disord 35:53\u201357. https:\/\/doi.org\/10.1016\/j.nmd.2023.10.018","journal-title":"Neuromuscul Disord"},{"key":"12538_CR109","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00415-017-8525-9","volume":"264","author":"S Moreira","year":"2017","unstructured":"Moreira S, Wood L, Smith D et al (2017) Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy. J Neurol 264:1271\u20131280. https:\/\/doi.org\/10.1007\/s00415-017-8525-9","journal-title":"J Neurol"},{"key":"12538_CR110","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1183\/09031936.06.00007906","volume":"27","author":"J-W Fitting","year":"2006","unstructured":"Fitting J-W (2006) Sniff nasal inspiratory pressure: simple or too simple? Eur Respir J 27:881\u2013883. https:\/\/doi.org\/10.1183\/09031936.06.00007906","journal-title":"Eur Respir J"},{"key":"12538_CR111","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pneumo.2017.10.001","volume":"73","author":"P Priou","year":"2017","unstructured":"Priou P, Trzepizur W, Meslier N, Gagnadoux F (2017) Update on the respiratory management of patients with chronic neuromuscular disease. Rev Pneumol Clin 73:316\u2013322. https:\/\/doi.org\/10.1016\/j.pneumo.2017.10.001","journal-title":"Rev Pneumol Clin"},{"key":"12538_CR112","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.4187\/respcare.06136","volume":"63","author":"MJP Oliveira","year":"2018","unstructured":"Oliveira MJP, Rodrigues F, Firmino-Machado J et al (2018) Assessment of respiratory muscle weakness in subjects with neuromuscular disease. Respir Care 63:1223\u20131230. https:\/\/doi.org\/10.4187\/respcare.06136","journal-title":"Respir Care"},{"key":"12538_CR113","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1212\/WNL.0000000000005915","volume":"91","author":"M Wohlgemuth","year":"2018","unstructured":"Wohlgemuth M, Lemmers RJ, Jonker M et al (2018) A family-based study into penetrance in facioscapulohumeral muscular dystrophy type 1. Neurology 91:e444\u2013e454. https:\/\/doi.org\/10.1212\/WNL.0000000000005915","journal-title":"Neurology"},{"key":"12538_CR114","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/mus.26717","volume":"60","author":"C Henke","year":"2019","unstructured":"Henke C, Spiesshoefer J, Kabitz H-J et al (2019) Respiratory muscle weakness in facioscapulohumeral muscular dystrophy. Muscle Nerve 60:679\u2013686. https:\/\/doi.org\/10.1002\/mus.26717","journal-title":"Muscle Nerve"},{"key":"12538_CR115","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.rmed.2017.03.023","volume":"126","author":"F Trucco","year":"2017","unstructured":"Trucco F, Pedemonte M, Fiorillo C et al (2017) Respiratory pattern in a FSDH paediatric population. Respir Med 126:132. https:\/\/doi.org\/10.1016\/j.rmed.2017.03.023","journal-title":"Respir Med"},{"key":"12538_CR116","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.rmed.2017.03.007","volume":"126","author":"CR van Kernebeek","year":"2017","unstructured":"van Kernebeek CR, Seijger CGW, Goselink RJM et al (2017) Respiratory pattern in a FSHD pediatric population. Respir Med 126:130\u2013131. https:\/\/doi.org\/10.1016\/j.rmed.2017.03.007","journal-title":"Respir Med"},{"key":"12538_CR117","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/CND.0000000000000144","volume":"18","author":"F Labombarda","year":"2017","unstructured":"Labombarda F, Maurice M, Simon J-P et al (2017) Cardiac abnormalities in type 1 facioscapulohumeral muscular dystrophy. J Clin Neuromuscul Dis 18:199\u2013206. https:\/\/doi.org\/10.1097\/CND.0000000000000144","journal-title":"J Clin Neuromuscul Dis"},{"key":"12538_CR118","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1212\/WNL.0b013e3181c34aa6","volume":"73","author":"L van den Engel-Hoek","year":"2009","unstructured":"van den Engel-Hoek L, Erasmus CE, van Bruggen HW et al (2009) Dysphagia in spinal muscular atrophy type II: more than a bulbar problem? Neurology 73:1787\u20131791. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34aa6","journal-title":"Neurology"},{"key":"12538_CR119","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1212\/WNL.0000000000007013","volume":"92","author":"K Mul","year":"2019","unstructured":"Mul K, Berggren KN, Sills MY et al (2019) Effects of weakness of orofacial muscles on swallowing and communication in FSHD. Neurology 92:e957\u2013e963. https:\/\/doi.org\/10.1212\/WNL.0000000000007013","journal-title":"Neurology"},{"key":"12538_CR120","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1600-0404.2006.00737.x","volume":"115","author":"JS Kalkman","year":"2007","unstructured":"Kalkman JS, Schillings ML, Zwarts MJ et al (2007) Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I. Acta Neurol Scand 115:265\u2013270. https:\/\/doi.org\/10.1111\/j.1600-0404.2006.00737.x","journal-title":"Acta Neurol Scand"},{"key":"12538_CR121","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.nmd.2017.09.007","volume":"27","author":"RJM Goselink","year":"2017","unstructured":"Goselink RJM, Voermans NC, Okkersen K et al (2017) Early onset facioscapulohumeral dystrophy\u2014a systematic review using individual patient data. Neuromuscul Disord 27:1077\u20131083. https:\/\/doi.org\/10.1016\/j.nmd.2017.09.007","journal-title":"Neuromuscul Disord"},{"key":"12538_CR122","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.neuroimage.2006.04.226","volume":"32","author":"M Quarantelli","year":"2006","unstructured":"Quarantelli M, Lanzillo R, Del Vecchio W et al (2006) Modifications of brain tissue volumes in facioscapulohumeral dystrophy. Neuroimage 32:1237\u20131242. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.04.226","journal-title":"Neuroimage"},{"key":"12538_CR123","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/mus.25619","volume":"56","author":"H Chagarlamudi","year":"2017","unstructured":"Chagarlamudi H, Corbett A, Stoll M et al (2017) Bone health in facioscapulohumeral muscular dystrophy: a cross-sectional study. Muscle Nerve 56:1108\u20131113. https:\/\/doi.org\/10.1002\/mus.25619","journal-title":"Muscle Nerve"},{"key":"12538_CR124","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/mus.25991","volume":"57","author":"G Mor\u00eds","year":"2018","unstructured":"Mor\u00eds G, Wood L, Fern\u00e1Ndez-Torr\u00f3n R et al (2018) Chronic pain has a strong impact on quality of life in facioscapulohumeral muscular dystrophy. Muscle Nerve 57:380\u2013387. https:\/\/doi.org\/10.1002\/mus.25991","journal-title":"Muscle Nerve"},{"key":"12538_CR125","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neurol.2011.11.008","volume":"168","author":"S Attarian","year":"2012","unstructured":"Attarian S, Salort-Campana E, Nguyen K et al (2012) Recommendations for the management of facioscapulohumeral muscular dystrophy in 2011. Rev Neurol (Paris) 168:910\u2013918. https:\/\/doi.org\/10.1016\/j.neurol.2011.11.008","journal-title":"Rev Neurol (Paris)"},{"key":"12538_CR126","doi-asserted-by":"crossref","unstructured":"Gargiulo M, Angeard N, Bassez G et al (2019) L\u2019annonce d\u2019une maladie neuromusculaire \u00e0 un patient adulte\u202f: et apr\u00e8s\u202f? In: Quand le handicap s\u2019invite au cours de la vie, Cairn. pp 145\u2013165","DOI":"10.3917\/eres.boiss.2019.01.0145"},{"key":"12538_CR127","unstructured":"(2008) Annonce d\u2019un dommage associ\u00e9 aux soins. In: Haute Autorit\u00e9 de Sant\u00e9. https:\/\/www.has-sante.fr\/jcms\/c_953138\/fr\/annonce-d-un-dommage-associe-aux-soins. Accessed 28 July 2023"},{"key":"12538_CR128","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13311-018-00675-3","volume":"15","author":"J Hamel","year":"2018","unstructured":"Hamel J, Tawil R (2018) Facioscapulohumeral muscular dystrophy: update on pathogenesis and future treatments. Neurotherapeutics 15:863\u2013871. https:\/\/doi.org\/10.1007\/s13311-018-00675-3","journal-title":"Neurotherapeutics"},{"key":"12538_CR129","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/cge.14031","volume":"101","author":"SCC Vincenten","year":"2022","unstructured":"Vincenten SCC, Van Der Stoep N, Paulussen ADC et al (2022) Facioscapulohumeral muscular dystrophy\u2014reproductive counseling, pregnancy, and delivery in a complex multigenetic disease. Clin Genet 101:149\u2013160. https:\/\/doi.org\/10.1111\/cge.14031","journal-title":"Clin Genet"},{"key":"12538_CR130","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.nmd.2006.08.005","volume":"16","author":"EL van der Kooi","year":"2006","unstructured":"van der Kooi EL, de Greef JC, Wohlgemuth M et al (2006) No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy. Neuromuscul Disord 16:766\u2013769. https:\/\/doi.org\/10.1016\/j.nmd.2006.08.005","journal-title":"Neuromuscul Disord"},{"key":"12538_CR131","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2014.09.014","volume":"81","author":"E Passerieux","year":"2015","unstructured":"Passerieux E, Hayot M, Jaussent A et al (2015) Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: a double-blind randomized controlled clinical trial. Free Radic Biol Med 81:158\u2013169. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.09.014","journal-title":"Free Radic Biol Med"},{"key":"12538_CR132","doi-asserted-by":"publisher","first-page":"7020295","DOI":"10.1155\/2017\/7020295","volume":"2017","author":"AP Denny","year":"2017","unstructured":"Denny AP, Heather AK (2017) Are antioxidants a potential therapy for FSHD? A review of the literature. Oxid Med Cell Longev 2017:7020295. https:\/\/doi.org\/10.1155\/2017\/7020295","journal-title":"Oxid Med Cell Longev"},{"key":"12538_CR133","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.apmr.2007.07.024","volume":"88","author":"EH Cup","year":"2007","unstructured":"Cup EH, Pieterse AJ, Ten Broek-Pastoor JM et al (2007) Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch Phys Med Rehabil 88:1452\u20131464. https:\/\/doi.org\/10.1016\/j.apmr.2007.07.024","journal-title":"Arch Phys Med Rehabil"},{"key":"12538_CR134","doi-asserted-by":"publisher","first-page":"CD003907","DOI":"10.1002\/14651858.CD003907.pub5","volume":"12","author":"NB Voet","year":"2019","unstructured":"Voet NB, van der Kooi EL, van Engelen BG, Geurts AC (2019) Strength training and aerobic exercise training for muscle disease. Cochrane Database Syst Rev 12:CD003907. https:\/\/doi.org\/10.1002\/14651858.CD003907.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"12538_CR135","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1212\/01.WNL.0000150584.45055.27","volume":"64","author":"DB Olsen","year":"2005","unstructured":"Olsen DB, \u00d8rngreen MC, Vissing J (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64:1064\u20131066. https:\/\/doi.org\/10.1212\/01.WNL.0000150584.45055.27","journal-title":"Neurology"},{"key":"12538_CR136","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1212\/WNL.0000000000001008","volume":"83","author":"N Voet","year":"2014","unstructured":"Voet N, Bleijenberg G, Hendriks J et al (2014) Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD: an RCT. Neurology 83:1914\u20131922. https:\/\/doi.org\/10.1212\/WNL.0000000000001008","journal-title":"Neurology"},{"key":"12538_CR137","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004497","volume":"95","author":"L-C Bankol\u00e9","year":"2016","unstructured":"Bankol\u00e9 L-C, Millet GY, Temesi J et al (2016) Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: a randomized controlled trial. Medicine (Baltimore) 95:e4497. https:\/\/doi.org\/10.1097\/MD.0000000000004497","journal-title":"Medicine (Baltimore)"},{"key":"12538_CR138","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00415-017-8497-9","volume":"264","author":"G Andersen","year":"2017","unstructured":"Andersen G, Heje K, Buch AE, Vissing J (2017) High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trial. J Neurol 264:1099\u20131106. https:\/\/doi.org\/10.1007\/s00415-017-8497-9","journal-title":"J Neurol"},{"key":"12538_CR139","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.otsr.2016.12.012","volume":"103","author":"M Le Hanneur","year":"2017","unstructured":"Le Hanneur M, Saint-Cast Y (2017) Long-term results of letournel scapulothoracic fusion in facioscapulohumeral muscular dystrophy: a retrospective study of eight cases. Orthop Traumatol Surg Res 103:421\u2013425. https:\/\/doi.org\/10.1016\/j.otsr.2016.12.012","journal-title":"Orthop Traumatol Surg Res"},{"key":"12538_CR140","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.jse.2013.04.012","volume":"23","author":"AD Cooney","year":"2014","unstructured":"Cooney AD, Gill I, Stuart PR (2014) The outcome of scapulothoracic arthrodesis using cerclage wires, plates, and allograft for facioscapulohumeral dystrophy. J Shoulder Elbow Surg 23:e8-13. https:\/\/doi.org\/10.1016\/j.jse.2013.04.012","journal-title":"J Shoulder Elbow Surg"},{"key":"12538_CR141","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jse.2005.10.015","volume":"15","author":"YG Rhee","year":"2006","unstructured":"Rhee YG, Ha JH (2006) Long-term results of scapulothoracic arthrodesis of facioscapulohumeral muscular dystrophy. J Shoulder Elbow Surg 15:445\u2013450. https:\/\/doi.org\/10.1016\/j.jse.2005.10.015","journal-title":"J Shoulder Elbow Surg"},{"key":"12538_CR142","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jse.2013.08.009","volume":"23","author":"DP Goel","year":"2014","unstructured":"Goel DP, Romanowski JR, Shi LL, Warner JJP (2014) Scapulothoracic fusion: outcomes and complications. J Shoulder Elbow Surg 23:542\u2013547. https:\/\/doi.org\/10.1016\/j.jse.2013.08.009","journal-title":"J Shoulder Elbow Surg"},{"key":"12538_CR143","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1302\/0301-620X.100B7.BJJ-2017-1438.R1","volume":"100B","author":"A Er\u015fen","year":"2018","unstructured":"Er\u015fen A, Atalar AC, Bayram S et al (2018) Long-term results of scapulothoracic arthrodesis with multiple cable method for facioscapulohumeral dystrophy: do the results deteriorate over time? Bone Joint J 100B:953\u2013956. https:\/\/doi.org\/10.1302\/0301-620X.100B7.BJJ-2017-1438.R1","journal-title":"Bone Joint J"},{"key":"12538_CR144","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/S2352-5800(15)30012-5","volume":"1","author":"B Plaud","year":"2015","unstructured":"Plaud B, Devys J-M (2015) Prise en charge anesth\u00e9sique dans les maladies neuromusculaires. Anesth R\u00e9anim 1:S53\u2013S60. https:\/\/doi.org\/10.1016\/S2352-5800(15)30012-5","journal-title":"Anesth R\u00e9anim"},{"key":"12538_CR145","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11910-020-01064-0","volume":"20","author":"E Crisan","year":"2020","unstructured":"Crisan E, Patil VK (2020) Neuromuscular complications of statin therapy. Curr Neurol Neurosci Rep 20:47. https:\/\/doi.org\/10.1007\/s11910-020-01064-0","journal-title":"Curr Neurol Neurosci Rep"},{"key":"12538_CR146","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neurol.2020.09.014","volume":"177","author":"B Zagorda","year":"2021","unstructured":"Zagorda B, Camdessanch\u00e9 J-P, F\u00e9asson L (2021) Pregnancy and myopathies: reciprocal impacts between pregnancy, delivery, and myopathies and their treatments. A clinical review. Rev Neurol (Paris) 177:225\u2013234. https:\/\/doi.org\/10.1016\/j.neurol.2020.09.014","journal-title":"Rev Neurol (Paris)"},{"key":"12538_CR147","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1212\/01.wnl.0000244471.05316.19","volume":"67","author":"E Ciafaloni","year":"2006","unstructured":"Ciafaloni E, Pressman EK, Loi AM et al (2006) Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy. Neurology 67:1887\u20131889. https:\/\/doi.org\/10.1212\/01.wnl.0000244471.05316.19","journal-title":"Neurology"},{"key":"12538_CR148","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/archneur.1997.00550190076017","volume":"54","author":"S Rudnik-Sch\u00f6neborn","year":"1997","unstructured":"Rudnik-Sch\u00f6neborn S, Glauner B, R\u00f6hrig D, Zerres K (1997) Obstetric aspects in women with facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and congenital myopathies. Arch Neurol 54:888\u2013894. https:\/\/doi.org\/10.1001\/archneur.1997.00550190076017","journal-title":"Arch Neurol"},{"key":"12538_CR149","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejogrb.2012.02.020","volume":"162","author":"C Awater","year":"2012","unstructured":"Awater C, Zerres K, Rudnik-Sch\u00f6neborn S (2012) Pregnancy course and outcome in women with hereditary neuromuscular disorders: comparison of obstetric risks in 178 patients. Eur J Obstet Gynecol Reprod Biol 162:153\u2013159. https:\/\/doi.org\/10.1016\/j.ejogrb.2012.02.020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"12538_CR150","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/WCO.0000000000001176","volume":"36","author":"V Salsi","year":"2023","unstructured":"Salsi V, Vattemi GNA, Tupler RG (2023) The FSHD jigsaw: are we placing the tiles in the right position? Curr Opin Neurol 36:455\u2013463. https:\/\/doi.org\/10.1097\/WCO.0000000000001176","journal-title":"Curr Opin Neurol"},{"key":"12538_CR151","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/cge.12000","volume":"83","author":"SG Mehta","year":"2013","unstructured":"Mehta SG, Khare M, Ramani R et al (2013) Genotype\u2013phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and\/or frontotemporal dementia. Clin Genet 83:422\u2013431. https:\/\/doi.org\/10.1111\/cge.12000","journal-title":"Clin Genet"},{"key":"12538_CR152","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13023-020-01551-0","volume":"15","author":"C Ikenaga","year":"2020","unstructured":"Ikenaga C, Findlay AR, Seiffert M et al (2020) Phenotypic diversity in an international cure VCP disease registry. Orphanet J Rare Dis 15:267. https:\/\/doi.org\/10.1186\/s13023-020-01551-0","journal-title":"Orphanet J Rare Dis"},{"key":"12538_CR153","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.1007\/s00415-023-11862-4","volume":"270","author":"D Esteller","year":"2023","unstructured":"Esteller D, Schiava M, Villar-Quiles R-N et al (2023) Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis. J Neurol 270:5849\u20135865. https:\/\/doi.org\/10.1007\/s00415-023-11862-4","journal-title":"J Neurol"},{"key":"12538_CR154","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.nmd.2009.06.372","volume":"19","author":"G Astrea","year":"2009","unstructured":"Astrea G, Schessl J, Clement E et al (2009) Muscle MRI in FHL1-linked reducing body myopathy. Neuromuscul Disord 19:689\u2013691. https:\/\/doi.org\/10.1016\/j.nmd.2009.06.372","journal-title":"Neuromuscul Disord"},{"key":"12538_CR155","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/brain\/awn325","volume":"132","author":"J Schessl","year":"2009","unstructured":"Schessl J, Taratuto AL, Sewry C et al (2009) Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain 132:452\u2013464. https:\/\/doi.org\/10.1093\/brain\/awn325","journal-title":"Brain"},{"key":"12538_CR156","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s10038-019-0627-z","volume":"64","author":"Z Hu","year":"2019","unstructured":"Hu Z, Zhu Y, Liu X et al (2019) FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy. J Hum Genet 64:919\u2013926. https:\/\/doi.org\/10.1038\/s10038-019-0627-z","journal-title":"J Hum Genet"},{"key":"12538_CR157","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1148\/radiol.2402050405","volume":"240","author":"CM Gaskin","year":"2006","unstructured":"Gaskin CM, Helms CA (2006) Parsonage-Turner syndrome: MR imaging findings and clinical information of 27 patients. Radiology 240:501\u2013507. https:\/\/doi.org\/10.1148\/radiol.2402050405","journal-title":"Radiology"},{"key":"12538_CR158","doi-asserted-by":"publisher","first-page":"W39","DOI":"10.2214\/AJR.06.1136","volume":"189","author":"RE Scalf","year":"2007","unstructured":"Scalf RE, Wenger DE, Frick MA et al (2007) MRI findings of 26 patients with Parsonage-Turner syndrome. AJR Am J Roentgenol 189:W39-44. https:\/\/doi.org\/10.2214\/AJR.06.1136","journal-title":"AJR Am J Roentgenol"},{"key":"12538_CR159","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11420-010-9176-x","volume":"6","author":"JH Feinberg","year":"2010","unstructured":"Feinberg JH, Radecki J (2010) Parsonage-turner syndrome. HSS J 6:199\u2013205. https:\/\/doi.org\/10.1007\/s11420-010-9176-x","journal-title":"HSS J"},{"key":"12538_CR160","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mus.25008","volume":"53","author":"JJJ Van Eijk","year":"2016","unstructured":"Van Eijk JJJ, Groothuis JT, Van Alfen N (2016) Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment. Muscle Nerve 53:337\u2013350. https:\/\/doi.org\/10.1002\/mus.25008","journal-title":"Muscle Nerve"},{"key":"12538_CR161","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1212\/WNL.0b013e31818da91e","volume":"71","author":"B Bembi","year":"2008","unstructured":"Bembi B, Cerini E, Danesino C et al (2008) Diagnosis of glycogenosis type II. Neurology 71:S4-11. https:\/\/doi.org\/10.1212\/WNL.0b013e31818da91e","journal-title":"Neurology"},{"key":"12538_CR162","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","volume":"372","author":"AT van der Ploeg","year":"2008","unstructured":"van der Ploeg AT, Reuser AJJ (2008) Pompe\u2019s disease. Lancet 372:1342\u20131353. https:\/\/doi.org\/10.1016\/S0140-6736(08)61555-X","journal-title":"Lancet"},{"key":"12538_CR163","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/1750-1172-8-159","volume":"8","author":"S Sampaolo","year":"2013","unstructured":"Sampaolo S, Esposito T, Farina O et al (2013) Distinct disease phenotypes linked to different combinations of GAA mutations in a large late-onset GSDII sibship. Orphanet J Rare Dis 8:159. https:\/\/doi.org\/10.1186\/1750-1172-8-159","journal-title":"Orphanet J Rare Dis"},{"key":"12538_CR164","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1590\/0004-282x20130022","volume":"71","author":"LC Werneck","year":"2013","unstructured":"Werneck LC, Lorenzoni PJ, Kay CSK, Scola RH (2013) Muscle biopsy in Pompe disease. Arq Neuropsiquiatr 71:284\u2013289. https:\/\/doi.org\/10.1590\/0004-282x20130022","journal-title":"Arq Neuropsiquiatr"},{"key":"12538_CR165","doi-asserted-by":"publisher","first-page":"15856","DOI":"10.18632\/aging.103794","volume":"12","author":"S Taverna","year":"2020","unstructured":"Taverna S, Cammarata G, Colomba P et al (2020) Pompe disease: pathogenesis, molecular genetics and diagnosis. Aging (Albany NY) 12:15856\u201315874. https:\/\/doi.org\/10.18632\/aging.103794","journal-title":"Aging (Albany NY)"},{"key":"12538_CR166","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","volume":"28","author":"M Ishizaki","year":"2018","unstructured":"Ishizaki M, Kobayashi M, Adachi K et al (2018) Female dystrophinopathy: review of current literature. Neuromuscul Disord 28:572\u2013581. https:\/\/doi.org\/10.1016\/j.nmd.2018.04.005","journal-title":"Neuromuscul Disord"},{"key":"12538_CR167","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1468-1331.2012.03753.x","volume":"19","author":"G Tasca","year":"2012","unstructured":"Tasca G, Monforte M, Iannaccone E et al (2012) Muscle MRI in female carriers of dystrophinopathy. Eur J Neurol 19:1256\u20131260. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03753.x","journal-title":"Eur J Neurol"},{"key":"12538_CR168","volume-title":"GeneReviews\u00ae","author":"C Angelini","year":"1993","unstructured":"Angelini C (1993) Calpainopathy. In: Adam MP, Mirzaa GM, Pagon RA et al (eds) GeneReviews\u00ae. University of Washington, Seattle, Seattle, WA"},{"key":"12538_CR169","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00415-019-09539-y","volume":"267","author":"A Barp","year":"2020","unstructured":"Barp A, Laforet P, Bello L et al (2020) European muscle MRI study in limb girdle muscular dystrophy type R1\/2A (LGMDR1\/LGMD2A). J Neurol 267:45\u201356. https:\/\/doi.org\/10.1007\/s00415-019-09539-y","journal-title":"J Neurol"},{"key":"12538_CR170","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/nan.12624","volume":"46","author":"M Cerino","year":"2020","unstructured":"Cerino M, Campana-Salort E, Salvi A et al (2020) Novel CAPN3 variant associated with an autosomal dominant calpainopathy. Neuropathol Appl Neurobiol 46:564\u2013578. https:\/\/doi.org\/10.1111\/nan.12624","journal-title":"Neuropathol Appl Neurobiol"},{"key":"12538_CR171","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/mus.27686","volume":"66","author":"LU Aivazoglou","year":"2022","unstructured":"Aivazoglou LU, Guimar\u00e3es JB, Costa MAF et al (2022) Whole-body MRI in limb girdle muscular dystrophy type R1\/2A: correlation with clinical scores. Muscle Nerve 66:471\u2013478. https:\/\/doi.org\/10.1002\/mus.27686","journal-title":"Muscle Nerve"},{"key":"12538_CR172","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1111\/ene.14821","volume":"28","author":"G Fern\u00e1ndez-Eulate","year":"2021","unstructured":"Fern\u00e1ndez-Eulate G, Querin G, Moore U et al (2021) Deep phenotyping of an international series of patients with late-onset dysferlinopathy. Eur J Neurol 28:2092\u20132102. https:\/\/doi.org\/10.1111\/ene.14821","journal-title":"Eur J Neurol"},{"key":"12538_CR173","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/mus.27419","volume":"64","author":"S Holm-Yildiz","year":"2021","unstructured":"Holm-Yildiz S, Witting N, de Stricker BJ et al (2021) Muscle biopsy and MRI findings in ANO5-related myopathy. Muscle Nerve 64:743\u2013748. https:\/\/doi.org\/10.1002\/mus.27419","journal-title":"Muscle Nerve"},{"key":"12538_CR174","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad088","author":"A de Bruyn","year":"2023","unstructured":"de Bruyn A, Montagnese F, Holm-Yildiz S et al (2023) Anoctamin-5 related muscle disease: clinical and genetic findings in a large European cohort. Brain. https:\/\/doi.org\/10.1093\/brain\/awad088","journal-title":"Brain"},{"key":"12538_CR175","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.nmd.2008.01.009","volume":"18","author":"N Carboni","year":"2008","unstructured":"Carboni N, Mura M, Marrosu G et al (2008) Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation. Neuromuscul Disord 18:291\u2013298. https:\/\/doi.org\/10.1016\/j.nmd.2008.01.009","journal-title":"Neuromuscul Disord"},{"key":"12538_CR176","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/ana.21846","volume":"67","author":"E Mercuri","year":"2010","unstructured":"Mercuri E, Clements E, Offiah A et al (2010) Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine. Ann Neurol 67:201\u2013208. https:\/\/doi.org\/10.1002\/ana.21846","journal-title":"Ann Neurol"},{"key":"12538_CR177","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/cells5030033","volume":"5","author":"L Maggi","year":"2016","unstructured":"Maggi L, Carboni N, Bernasconi P (2016) Skeletal muscle laminopathies: a review of clinical and molecular features. Cells 5:33. https:\/\/doi.org\/10.3390\/cells5030033","journal-title":"Cells"},{"key":"12538_CR178","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/mus.26312","volume":"58","author":"D G\u00f3Mez-Andr\u00e9s","year":"2018","unstructured":"G\u00f3Mez-Andr\u00e9s D, D\u00edaz-Manera J, Alejaldre A et al (2018) Muscle imaging in laminopathies: synthesis study identifies meaningful muscles for follow-up. Muscle Nerve 58:812\u2013817. https:\/\/doi.org\/10.1002\/mus.26312","journal-title":"Muscle Nerve"},{"key":"12538_CR179","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1212\/01.wnl.0000324927.28817.9b","volume":"71","author":"D Fischer","year":"2008","unstructured":"Fischer D, Kley RA, Strach K et al (2008) Distinct muscle imaging patterns in myofibrillar myopathies. Neurology 71:758\u2013765. https:\/\/doi.org\/10.1212\/01.wnl.0000324927.28817.9b","journal-title":"Neurology"},{"key":"12538_CR180","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.neurol.2015.06.002","volume":"171","author":"A B\u00e9hin","year":"2015","unstructured":"B\u00e9hin A, Salort-Campana E, Wahbi K et al (2015) Myofibrillar myopathies: state of the art, present and future challenges. Rev Neurol (Paris) 171:715\u2013729. https:\/\/doi.org\/10.1016\/j.neurol.2015.06.002","journal-title":"Rev Neurol (Paris)"},{"key":"12538_CR181","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1172-9-88","volume":"9","author":"Q Gang","year":"2014","unstructured":"Gang Q, Bettencourt C, Machado P et al (2014) Sporadic inclusion body myositis: the genetic contributions to the pathogenesis. Orphanet J Rare Dis 9:88. https:\/\/doi.org\/10.1186\/1750-1172-9-88","journal-title":"Orphanet J Rare Dis"},{"key":"12538_CR182","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/mus.24661","volume":"52","author":"G Tasca","year":"2015","unstructured":"Tasca G, Monforte M, De Fino C et al (2015) Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis. Muscle Nerve 52:956\u2013962. https:\/\/doi.org\/10.1002\/mus.24661","journal-title":"Muscle Nerve"},{"key":"12538_CR183","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.2214\/AJR.17.17849","volume":"209","author":"JB Guimaraes","year":"2017","unstructured":"Guimaraes JB, Zanoteli E, Link TM et al (2017) Sporadic inclusion body myositis: MRI findings and correlation with clinical and functional parameters. AJR Am J Roentgenol 209:1340\u20131347. https:\/\/doi.org\/10.2214\/AJR.17.17849","journal-title":"AJR Am J Roentgenol"},{"key":"12538_CR184","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.2214\/AJR.08.1764","volume":"192","author":"M Schulze","year":"2009","unstructured":"Schulze M, K\u00f6tter I, Ernemann U et al (2009) MRI findings in inflammatory muscle diseases and their noninflammatory mimics. Am J Roentgenol 192:1708\u20131716. https:\/\/doi.org\/10.2214\/AJR.08.1764","journal-title":"Am J Roentgenol"},{"key":"12538_CR185","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/BOR.0000000000000652","volume":"31","author":"S Rothwell","year":"2019","unstructured":"Rothwell S, Chinoy H, Lamb JA (2019) Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis. Curr Opin Rheumatol 31:611\u2013616. https:\/\/doi.org\/10.1097\/BOR.0000000000000652","journal-title":"Curr Opin Rheumatol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12538-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12538-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12538-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T08:18:06Z","timestamp":1725524286000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12538-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,2]]},"references-count":185,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["12538"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12538-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,2]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}